Search research articles
Contact Us
Filters
Showing results (21-30 of 224) with videos related to
Page
of 23
Sort By:
Annales De La Societe Belge De Medecine Tropicale
|
March 1, 1982
[Variants of Trypanosoma cruzi with reduced virulence obtained by mutagen treatment in vitro]
T Boon, M Marchand
Current Opinion in Immunology
|
October 1, 1993
Tumor immunology: present perspectives
G Klein, T Boon
Parasite Immunology
|
May 1, 1984
Trypanosoma cruzi variants with reduced virulence obtained by mutagenesis
M Marchand, T Boon
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1977
Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line
T Boon, O Kellermann
European Journal of Immunology
|
May 1, 1982
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones
J L Maryanski, T Boon
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1982
Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis
A Van Pel, T Boon
Journal of Molecular Biology
|
May 28, 1971
Genotypes produced by individual recombination events involving bacteriophage f1
T Boon, N D Zinder
Virology
|
July 1, 1970
Genetic recombination in bacteriophage f1: transfer of parental DNA to the recombinant
T Boon, N D Zinder
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1978
Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line
T Boon, A Van Pel
Immunogenetics
|
January 1, 1989
T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis
T Boon, A Van Pel
Page
of 23
Search research articles
Search
Showing results (21-30 of 224) with videos related to
Sort By:
Page
of 23
Annales De La Societe Belge De Medecine Tropicale
|
March 1, 1982
[Variants of Trypanosoma cruzi with reduced virulence obtained by mutagen treatment in vitro]
T Boon, M Marchand
Current Opinion in Immunology
|
October 1, 1993
Tumor immunology: present perspectives
G Klein, T Boon
Parasite Immunology
|
May 1, 1984
Trypanosoma cruzi variants with reduced virulence obtained by mutagenesis
M Marchand, T Boon
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1977
Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line
T Boon, O Kellermann
European Journal of Immunology
|
May 1, 1982
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones
J L Maryanski, T Boon
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1982
Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis
A Van Pel, T Boon
Journal of Molecular Biology
|
May 28, 1971
Genotypes produced by individual recombination events involving bacteriophage f1
T Boon, N D Zinder
Virology
|
July 1, 1970
Genetic recombination in bacteriophage f1: transfer of parental DNA to the recombinant
T Boon, N D Zinder
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1978
Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line
T Boon, A Van Pel
Immunogenetics
|
January 1, 1989
T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis
T Boon, A Van Pel
Page
of 23